TH-237ACAS# 935467-97-3 |
2D Structure
- ZSTK474
Catalog No.:BCC3657
CAS No.:475110-96-4
- PIK-90
Catalog No.:BCC1248
CAS No.:677338-12-4
- CAL-101 (Idelalisib, GS-1101)
Catalog No.:BCC1270
CAS No.:870281-82-6
- GDC-0941
Catalog No.:BCC3626
CAS No.:957054-30-7
- GDC-0941 dimethanesulfonate
Catalog No.:BCC1590
CAS No.:957054-33-0
- NVP-QAV-572
Catalog No.:BCC4181
CAS No.:957209-68-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 935467-97-3 | SDF | Download SDF |
PubChem ID | 16722711 | Appearance | Powder |
Formula | C18H17F2NO3 | M.Wt | 333.33 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | meso-GS 164 | ||
Solubility | DMSO : ≥ 46 mg/mL (138.00 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | [(3R,5S)-3,5-bis(4-fluorophenyl)-1,3,5,7-tetrahydro-[1,3]oxazolo[3,4-c][1,3]oxazol-7a-yl]methanol | ||
SMILES | C1C2(COC(N2C(O1)C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)CO | ||
Standard InChIKey | AEZQGSQEXPUADE-JWTNVVGKSA-N | ||
Standard InChI | InChI=1S/C18H17F2NO3/c19-14-5-1-12(2-6-14)16-21-17(13-3-7-15(20)8-4-13)24-11-18(21,9-22)10-23-16/h1-8,16-17,22H,9-11H2/t16-,17+,18? | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
TH-237A Dilution Calculator
TH-237A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3 mL | 15.0002 mL | 30.0003 mL | 60.0006 mL | 75.0008 mL |
5 mM | 0.6 mL | 3 mL | 6.0001 mL | 12.0001 mL | 15.0002 mL |
10 mM | 0.3 mL | 1.5 mL | 3 mL | 6.0001 mL | 7.5001 mL |
50 mM | 0.06 mL | 0.3 mL | 0.6 mL | 1.2 mL | 1.5 mL |
100 mM | 0.03 mL | 0.15 mL | 0.3 mL | 0.6 mL | 0.75 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
TH-237A(meso-GS 164) is a novel neuroprotective agent exhibiting favorable permeation across the blood brain barrier. IC50 value: 5 nM (EC50, concentration that leads to a 50% increase in neuronal survival in the presence of the Aβ peptides) Target: Primary neurons were isolated from embryonic Sprague-Dawley rats, grown in culture (Michaelis et al., 1994) and exposed to either Aβ25-35 or Aβ1-42 in the presence or absence of TH-237A at concentrations ranging from 0.5 to 60 nM. The neurons were treated with TH-237A for 2 hours prior to exposure to the Aβ peptides. Changes in neuronal survival following treatment with TH 237A were evaluated using the Live/Dead assay. The EC50 for TH-237A was 5 nM, demonstrating that it had excellent neuroprotective properties.
References:
[1]. Kelly E. Desino, Improving Blood Brain Barrier Permeation of Small Molecules Exhibiting Chemotherapeutic and Neuroprotective Effects.
- (4->2)-Abeo-16-hydroxycleroda-2,13-dien-15,16-olide-3-al
Catalog No.:BCN7498
CAS No.:935293-70-2
- 2-Iodomelatonin
Catalog No.:BCC6772
CAS No.:93515-00-5
- Glimepiride
Catalog No.:BCC2109
CAS No.:93479-97-1
- Karavilagenin D
Catalog No.:BCN4480
CAS No.:934739-29-4
- Cobimetinib (racemate)
Catalog No.:BCC1492
CAS No.:934662-91-6
- Cobimetinib (R-enantiomer)
Catalog No.:BCC1493
CAS No.:934660-94-3
- Cobimetinib
Catalog No.:BCC1491
CAS No.:934660-93-2
- 8-Deacetylyunaconitine
Catalog No.:BCN7609
CAS No.:93460-55-0
- TAK-901
Catalog No.:BCC2180
CAS No.:934541-31-8
- Glucoliquiritin
Catalog No.:BCN6760
CAS No.:93446-18-5
- Conantokin G
Catalog No.:BCC6120
CAS No.:93438-65-4
- ENMD-2076
Catalog No.:BCC2186
CAS No.:934353-76-1
- Euphorbia factor L7a
Catalog No.:BCN3784
CAS No.:93550-94-8
- MDL 72527
Catalog No.:BCC6060
CAS No.:93565-01-6
- AZD1480
Catalog No.:BCC2191
CAS No.:935666-88-9
- BIX 01294
Catalog No.:BCC1131
CAS No.:935693-62-2
- AR-42 (OSU-HDAC42)
Catalog No.:BCC2161
CAS No.:935881-37-1
- Oprozomib (ONX-0912)
Catalog No.:BCC1146
CAS No.:935888-69-0
- 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methylbut-1-enyl)benzene-1,3-diol
Catalog No.:BCN1304
CAS No.:936006-11-0
- Daphnenone
Catalog No.:BCN3229
CAS No.:936006-13-2
- cAMPS-Sp, triethylammonium salt
Catalog No.:BCC8081
CAS No.:93602-66-5
- TG101209
Catalog No.:BCC2198
CAS No.:936091-14-4
- TG101348 (SAR302503)
Catalog No.:BCC2190
CAS No.:936091-26-8
- ACET
Catalog No.:BCC7462
CAS No.:936095-50-0